NCT05353894View on ClinicalTrials.gov

Effect of Food and Formulation on the Pharmacokinetics, Safety, and Tolerability of GNS561 After One Single Dose (50 and 200mg) in Healthy Volunteers

PHASE1UnknownINTERVENTIONAL

Enrollment

27

Participants

Timeline

Start Date

May 2, 2022

Primary Completion Date

November 30, 2022

Study Completion Date

November 30, 2022

Conditions

Primary Liver Cancer

Interventions

DRUG

GNS561 oral tablets and capsules

Two formulations and Two dosage will be compared

Trial Locations (1)

13006

Genoscience Pharma, Marseille

Sponsors

Lead Sponsor

Genoscience Pharma

All Listed Sponsors

lead

Genoscience Pharma

INDUSTRY

NCT05353894 - Effect of Food and Formulation on the Pharmacokinetics, Safety, and Tolerability of GNS561 After One Single Dose (50 and 200mg) in Healthy Volunteers | Biotech Hunter | Biotech Hunter